Skip to main content
. 2022 Jun 7;23(12):6381. doi: 10.3390/ijms23126381
ALK Anaplastic lymphoma kinase
AML Acute myeloid leukemia
BTK Bruton’s tyrosine kinase
Car-DPPYs carbonyl-substituted diphenylpyrimidine derivatives
DFG (Asp-Phe-Gly) motif
DPPYs Diphenylpyrimidine analogs
EGFR Endothelial growth factor receptor
ERK Extracellular signal-regulated kinases
FAK Focal adhesion kinase
FAKIs FAK inhibitors
FAT Focal Adhesion Targeting
GBM Malignant glioblastoma
Grb2 Growth factor receptor-bound protein 2
HCC Hepatocellular carcinoma cell
HDAC histone deacetylases
HUVEC Human Umbilical Vein Endothelial Cells
IGF-IR Insulin-like growth factor-I receptor
JNK Janus kinase
MAPK Mitogen-activated protein kinase kinase
NSCLC Non-small cell lung cancer
NF-kB Nuclear factor-κB
PA-DPPYs phosphamide-containing diphenylpyrimidine analogs
PC pancreatic cells
PDGFR Platelet-derived growth factor receptor
PET Positron emission tomography
PROTAC Proteolysis targeting chimera
PRP Poly-prolin- rich sequences
Pyk2 Proline-rich tyrosine kinase 2
ROS reactive oxygen species
Sul-DPPYs sulphonamide-substituted diphenylpyrimidine derivatives
TOP1 Topoisomerase I
VEGFR Vascular endothelial growth factor receptor
VHL Von Hippel-Lindau